Literature DB >> 10976932

Opioid- and GABA(A)-receptors are co-expressed by neurons in rat brain.

A E Kalyuzhny1, J Dooyema, M W Wessendorf.   

Abstract

Pharmacological data suggest that opioids exert their excitatory action in brain indirectly, by inhibiting release of the inhibitory neurotransmitter GABA. However, it is also possible that single neuron may interact with both opioids and GABA. In the present study, we investigated whether neurons in rat midbrain and medulla express both opioid and GABA(A) receptors. Coronal sections through rat brain were double-stained using antibodies against the alpha 1 subunit of GABA(A) receptor that were combined with antibodies either against the cloned mu-opioid receptor (MOR1) or the cloned kappa-opioid receptor (KOR1). Neurons double-labeled for GABA(A) receptors and either MOR1 or KOR1 were found in many brain regions including inferior colliculus, mesencephalic trigeminal nuclei, pontine reticular nuclei and raphe interpositus nucleus. Neurons double-labeled for GABA(A) and MOR1 were observed less frequently than those labeled for GABA(A) and KOR1. Our findings provide anatomical evidence that GABAergic and opioidergic systems are closely linked and activity of the same neuron may be regulated directly by both GABA and opioids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10976932     DOI: 10.1097/00001756-200008210-00004

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

1.  Serotonin 1B receptor modulates frequency response curves and spectral integration in the inferior colliculus by reducing GABAergic inhibition.

Authors:  Laura M Hurley; Jo Anne Tracy; Alexander Bohorquez
Journal:  J Neurophysiol       Date:  2008-07-16       Impact factor: 2.714

2.  μ-Opioid modulation in the rostral solitary nucleus and reticular formation alters taste reactivity: evidence for a suppressive effect on consummatory behavior.

Authors:  Nicole R Kinzeler; Susan P Travers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-22       Impact factor: 3.619

Review 3.  Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.

Authors:  Caroline A Arout; Ellen Edens; Ismene L Petrakis; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

4.  Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine.

Authors:  C J Watson; R Lydic; H A Baghdoyan
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

Review 5.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

6.  Panicolytic-like effects caused by substantia nigra pars reticulata pretreatment with low doses of endomorphin-1 and high doses of CTOP or the NOP receptors antagonist JTC-801 in male Rattus norvegicus.

Authors:  Juliana Almeida da Silva; Audrey Franceschi Biagioni; Rafael Carvalho Almada; Renato Leonardo de Freitas; Norberto Cysne Coimbra
Journal:  Psychopharmacology (Berl)       Date:  2017-08-30       Impact factor: 4.530

7.  Morphine increases acetylcholine release in the trigeminal nuclear complex.

Authors:  Zhenghong Zhu; Heather R Bowman; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep       Date:  2008-12       Impact factor: 5.849

8.  Sex differences in micro-opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia.

Authors:  Dayna R Loyd; Xioaya Wang; Anne Z Murphy
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

9.  Autoradiographic analysis of GABAA receptors in mu-opioid receptor knockout mice.

Authors:  Lu-Tai Tien; Tangeng Ma; Lir-Wan Fan; Horace H Loh; Ing-Kang Ho
Journal:  Neurochem Res       Date:  2007-06-12       Impact factor: 3.996

10.  Accelerated kindling development in mu-opioid receptor deficient mice.

Authors:  G Grecksch; A Becker; H Schroeder; J Kraus; H Loh; V Höllt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.